Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (631-640 of 663) with videos related to

Pageof 67
Sort By:
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Nature Medicine|November 13, 2023
Viral and host mediators of non-suppressible HIV-1 viremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Pageof 67

Showing results (631-640 of 663) with videos related to

Sort By:
Pageof 67
AIDS (London, England)|July 22, 2022
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infectionMichael J Peluso, Matthew A Spinelli, Tyler-Marie Deveau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Science Translational Medicine|July 3, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infectionMichael J Peluso, Dylan Ryder, Robert R Flavell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
The Lancet. Infectious Diseases|February 13, 2025
Targeting the SARS-CoV-2 reservoir in long COVIDAmy D Proal, Soo Aleman, Morgane Bomsel, et al.
Nature Medicine|November 13, 2023
Viral and host mediators of non-suppressible HIV-1 viremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Science (New York, N.Y.)|April 6, 2013
Influence of HLA-C expression level on HIV controlRichard Apps, Ying Qi, Jonathan M Carlson, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Pageof 67